NAS:JAZZ (Ireland)   Healthcare » Biotechnology
Jazz Pharmaceuticals PLC logo

Jazz Pharmaceuticals PLC $ 179.29 1.13 (0.63%)

Volume:
389,375
Avg Vol (1m):
669,457
Market Cap $:
10.85 Bil
Enterprise Value $:
10.67 Bil
PE Ratio:
19.61
PB Ratio:
2.69
Warning! GuruFocus has detected 1 Severe warning sign with JAZZ. Click here to check it out.
Also Trade In: Germany Mexico
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

JAZZ News and Headlines - Jazz Pharmaceuticals PLC

GuruFocus Articles Total 30
  • 1
  • 2

Erkrath, 2M, based Investment company Lingohr & Partner Asset Management GmbH (Current Portfolio) buys Icon PLC, Nomad Foods, Stellantis NV, UBS Group AG, SLM Corp, sells Qurate Retail Inc, Western Alliance Bancorp, Kohl's Corp, Tapestry Inc, MasTec Inc during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Lingohr & Partner Asset Management GmbH. As of 2021Q1, Lingohr & Partner Asset Management GmbH owns 83 stocks with a total value of $40 million. These are the details of the buys and sells.
0 Views    insider    2021-05-12 17:38

The stock of Jazz Pharmaceuticals PLC (NAS:JAZZ, 30-year Financials) shows every sign of being modestly undervalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF

0 Views    GF Value    2021-03-30 00:12
Insiders loaded up on TJX Companies, Boston Properties, Royal Caribbean Cruises and Jazz Pharmaceuticals

The largest insider buys this week were in TJX Companies Inc. (TJX), Boston Properties Inc. (BXP), Royal Caribbean Cruises Ltd. (RCL) and Jazz Pharmaceuticals PLC (JAZZ).

TJX Companies director bought 3,000 shares

Director Rosemary T. Berkery bought 3,000 shares on May 22 for an average price of $53.48. The share price has decreased by 1.35% since then.

TJX Companies is an American retail company that operates the brands TJ Maxx, Marshalls, HomeGoods, HomeSense and Sierra. The company has over 3,300 stores in its portfolio that are located in more than six countries. The company was ranked number 85 in the

173 Views    Shuda Xia    2020-05-30 21:01
The newly public company develops therapies for genetic diseases

Guru Andreas Halvorsen (Trades, Portfolio), leader of Viking Global Investors, disclosed a stake in BridgeBio Pharma Inc. (BBIO) on Monday, adding to his health care holdings.

A former student of Tiger Management’s Julian Robertson (Trades, Portfolio), the investor’s Connecticut-based firm picks stocks based on its understanding of the business’ fundamentals and management team as well as cyclical and secular industry trends.

According to GuruFocus Real-Time Picks, a Premium feature, Halvorsen had invested in 26.6 million shares of the Palo Alto, California-based biopharmaceutical company as of June 27, dedicating approximately 4.04% of the equity

185 Views    Sydnee Gatewood    2019-07-02 16:48
Patrick Industries tops the list

According to the GuruFocus All-in-One Screener, the following companies look cheap since they are trading with low price-sales ratios.

Shares of Patrick Industries Inc. (PATK) are trading around $48.59 with a price-sales ratio of 0.52 and a price-earnings ratio of 9.86.

The building products and materials manufacturer has a market cap of $1.16 billion. The stock has climbed at an annualized rate of 68.86% over the last 10 years.

The discounted cash flow calculator gives the stock a fair value of $52.65, suggesting it is undervalued with a 7.71% margin of safety. The Peter Lynch

379 Views    Tiziano Frateschi    2019-05-07 16:07
Investor takes stake in newly public company

Guru Andreas Halvorsen (Trades, Portfolio), leader of Viking Global Investors, disclosed a 5.2% stake in Moderna Inc. (MRNA) on Dec. 11.

A former student of Tiger Management’s Julian Robertson (Trades, Portfolio), the investor’s Connecticut-based firm picks stocks based on its understanding of the business’ fundamentals, management team and cyclical and secular industry trends.

According to GuruFocus real-time picks, Halvorsen invested in 17.09 million shares of the Cambridge, Massachusetts-based biotechnology company for an average price of $18.01 per share. The stake was given 1.68% space in the equity portfolio.

The company, which develops messenger

389 Views    Sydnee Gatewood    2018-12-27 16:47
Guru sees value in biotech company

Viking Global Investors leader Andreas Halvorsen (Trades, Portfolio) disclosed an 81.2% stake in Axovant Sciences Ltd. (AXON) on Dec. 18.

The guru’s Greenwich, Connecticut-based firm picks stocks based on its understanding of the business’ fundamentals, management team and cyclical and secular industry trends.

According to GuruFocus real-time picks, Halvorsen invested in 99.3 million shares of the London-based clinical-stage pharmaceutical company for an average price of $1.06 per share. The stake was given 0.58% space in the equity portfolio.

The company, which develops small molecule drugs to treat neurological disorders, has a $127.79 million market cap; its

136 Views    Sydnee Gatewood    2018-12-21 17:45
Guru releases 2nd-quarter portfolio

Ronald Muhlenkamp (Trades, Portfolio), leader of investment firm Muhlenkamp & Co. Inc., disclosed in his second-quarter portfolio that he exchanged his Bristol-Myers Squibb Co. (BMY) holding for a position in Jazz Pharmaceuticals PLC (JAZZ).

With the goal of maximizing returns through capital appreciation, as well as income from dividends and interest, Muhlenkamp typically invests in highly profitable companies trading at a discount.

Bristol-Myers Squibb

In his largest trade of the quarter, Muhlenkamp cashed in on his 178,436 remaining shares of Bristol-Myers Squibb for an average price of $54.03 per share, impacting the equity portfolio by -4.09%. GuruFocus

195 Views    Sydnee Gatewood    2018-08-13 21:31
Agios, Jazz Pharmaceuticals on the list

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Three gurus are invested in Clovis Oncology Inc. (CLVA). The company acquires, develops and commercializes cancer treatments in main international markets. It has a market cap of $2.6 billion. Its revenue of $66.99 million has not changed over a 10-year period.

The stock is trading with a price-book ratio of 8.22. The current price of $49.48 is 50.25% below its 52-week high and 19.78% above its 52-week low. Over the past 10 years, it has returned a gain of 294%.

The company’s largest

70 Views    Tiziano Frateschi    2018-07-12 15:43
Guru invests in newly public biopharmaceutical company

Viking Global Investors leader Andreas Halvorsen (Trades, Portfolio) disclosed he established a 5.5% stake in Eidos Therapeutics Inc. (EIDX) on June 22.

According to GuruFocus real-time picks, Halvorsen, who picks stocks based on his understanding of the business' fundamentals, management team and cyclical and secular industry trends, invested in 1.9 million shares of Eidos for an average price of $21.90 per share, giving the holding 0.26% portfolio space.

The San Francisco-based clinical-stage biopharmaceutical company, which went public on June 20, has a market cap of $752.1 million; its shares were trading around $21 on Tuesday, up

589 Views    Sydnee Gatewood    2018-07-03 16:20
The company has in-licensed Noctiva, which has great market opportunity. It also has a phase 3 study with one of its drugs, FT218. If the study is positive, the stock has a lot of room to run

At present, Avadel Pharmaceuticals PLC (AVDL) is one of my favorite biotech stocks for a number of reasons:

  1. The availability of several markets’ products.
  2. A high-potential asset in the pipeline (FT218), which is currently in a phase three study.
  3. A newly in-licensed product (Noctiva), which has huge market potential.

My reason for buying Avadel is Noctiva. Why? Because it is already approved, is the only Food and Drug Administration-approved product for nocturia due to nocturnal polyuria (no competition) and has huge potential.

A look at each of these points will determine if Avadel can double.

Marketed products

8 Views    Robert Gadimian    2018-03-29 18:52
Gurus are buying these popular stocks

According to the GuruFocus All-In-One Screener, the following health care stocks have positions in gurus' portfolios.

Five gurus have positions in Anika Therapeutics Inc. (ANIK).

The biotechnology company has a market cap of $871.74 million. Its revenue grew 11.30% over the past 10 years and its earnings per share (EPS) increased 31.20%.

The stock is trading with a price-earnings (P/E) ratio of 26.34. The current stock price of $59.78 is 1.13% below its 52-week high and 43.72% above its 52-week low. Over the past decade, it has returned a gain of 193%.

In the second quarter, Ken Fisher

195 Views    Tiziano Frateschi    2017-10-16 18:24
Guru invests in biopharmaceutical company

Viking Global Investors LP Chief Investment Officer Andreas Halvorsen (Trades, Portfolio) established a stake in Abeona Therapeutics Inc. (ABEO) on Sept. 22, according to GuruFocus real-time picks.

Managing a portfolio of 53 stocks, Halvorsen invests largely in the technology sector. The firm, which he co-founded in 1999, seeks long-term investments based on fundamental analysis and thorough assessment of a company’s business model, management team and industry trends. The firm also focuses on risk management.

Halvorsen invested in 2.24 million shares of Abeona for an average price of $14.95 per share, giving it 0.22% portfolio space.

The

292 Views    Sydnee Gatewood    2017-10-03 16:22
Company's platform could be transformative in treating cancer

This article was originally featured on CNA Finance.

Start a free 7-day trial of Premium Membership to GuruFocus.

252 Views    Joshua Rodriguez    2017-02-13 20:54
Company's medical research adds to its valuation

[This article was originally featured on CNA Finance]

Start a free 7-day trial of Premium Membership to GuruFocus.

180 Views    Joshua Rodriguez    2017-02-07 21:45
Gurus buy shares of undervalued companies

According to GuruFocus' All-in-One Screener, several gurus are focusing on stocks whose Peter Lynch fair values are far above the current prices. The following stocks are trading with wide margins of safety and at least five gurus are shareholders.

Akorn Inc. (AKRX) is trading at about $22 per share. The Peter Lynch value gives the stock a fair price of $37 so the stock is undervalued with a margin of safety of 41%.

The stock is trading with a price-earnings (P/E) ratio of 15.24, higher than 79% of companies in the Global Drug Manufacturers - Specialty & Generic

566 Views    Tiziano Frateschi    2017-01-11 20:21
A look at triple buys for 2016

Among U.S. companies, Hertz Global Holdings Inc. (HTZ) and Aaron’s Inc. (AAN) have high guru, insider and company buys during 2016. Such companies, known as “triple buys,” offer good value potential for early 2017.

Brief recap of double buys and introduction to triple buys

In a previous article, we explored double buys, companies that both gurus and insiders have purchased shares in during the past three to six months. The list of double buys includes Hertz, Jazz Pharmaceuticals PLC (JAZZ) and Myriad Genetics Inc. (MYGN). Among these three companies, Hertz is also a “triple buy” as the company

487 Views    James Li    2017-01-04 22:49
Analysis of double buys across sectors

Among U.S. companies, industrial and medical companies have high guru and insider buys during 2016. Such companies include Hertz Global Holdings Inc. (HTZ), Jazz Pharmaceuticals PLC (JAZZ) and Myriad Genetics Inc. (MYGN). These double buys have good value potential in early 2017.

What is a double buy?

Double buys, as discussed in a research article, are companies that gurus and insiders have recently purchased shares in. Legendary investor Peter Lynch once claimed that insiders may sell their shares for several reasons, but insiders only buy shares for one reason: share price appreciation. Companies that have high insider buys

819 Views    James Li    2016-12-30 22:16
If 'Brexit means Brexit,' does 'Trump mean Trump'? We're not so sure.

The election of Donald Trump as the 45th U.S. president shocked many people around the world. The Electoral College recorded a decisive victory for Trump, although Hillary Clinton received more of the popular vote.

The Republican Party retained a majority of the U.S. Senate seats, but strong Democratic representation makes it a highly divided group. Republicans will also hold the majority in the House of Representatives, but cooperation — both between parties and within the two main parties themselves — will be necessary to move forward. We certainly do not believe the chambers of government are as one-sided as the

111 Views    Holly LaFon    2016-11-29 15:58
Health care sector moderately undervalued based on price-to-sales valuations

Among companies trading on the New York Stock Exchange and the Nasdaq, health care companies trade significantly below their median price-sales (P/S) valuation. At least five companies made the “Undervalued Biotech” screener, including Biogen Inc. (BIIB), Gilead Sciences Inc. (GILD), JAZZ Pharmaceuticals PLC (JAZZ), Novo Nordisk A/S (NVO) and United Therapeutics Corp. (UTHR). As these companies present strong value potential to investors and shareholders, several gurus have invested in these companies.

This article is Part 3 in a series of articles discussing how to visualize financial trends with interactive charts. In Part 1, we introduced interactive charts

3118 Views    James Li    2016-11-25 18:14

Headlines Total 112
  • 1
  • 2

2021-05-12 $ 175.9 (1.21%)
12:38pm
2021-05-06 $ 172.84 (1.18%)
12:13pm
3:15am
2021-05-05 $ 170.82 (6.63%)
4:54pm
8:25am
2021-05-04 $ 160.2 (-2.99%)
6:20pm
2021-04-22 $ 167.52 (-1.34%)
11:05am
10:40am
5:29am
2021-04-14 $ 166.37 (1.87%)
12:00pm
2021-04-13 $ 163.31 (0.63%)
8:33am
2021-03-31 $ 164.37 (-1.27%)
8:59am
2021-03-30 $ 167.52 (-0.53%)
7:12pm
2021-03-25 $ 166.66 (1.8%)
10:30am
2021-03-23 $ 164.31 (-3.68%)
9:18am
2021-03-18 $ 169.63 (-2.03%)
7:05am
2021-03-03 $ 162.91 (-1.71%)
4:42pm
4:15pm
2021-02-24 $ 173.5 (10.18%)
6:52am
6:00am
8:48pm
2021-02-23 $ 157.47 (-2.6%)
5:21pm
2021-02-22 $ 161.68 (0.67%)
7:19am
2021-02-18 $ 159.01 (-3.21%)
3:29pm
2021-02-11 $ 166.85 (1.13%)
6:38am
2021-02-10 $ 164.99 (-1.52%)
10:57am
9:30am
7:44am
2021-02-09 $ 167.54 (0.92%)
12:38pm
2021-02-06
6:30am
2021-02-05 $ 156.91 (4.47%)
11:45am
7:20am
2021-02-04 $ 150.19 (-0.67%)
9:10am
7:01pm
2021-01-06 $ 163.98 (1.01%)
4:15pm
2020-12-22 $ 151.51 (0.92%)
9:27am
2020-12-04 $ 150.71 (-0.19%)
7:44am
2020-12-02 $ 144.55 (0.99%)
10:30am
2020-11-20 $ 143.1 (-0.39%)
8:40am
2020-11-05 $ 157.33 (5.84%)
9:15pm
2020-11-04 $ 157.33 (5.84%)
6:56am
2020-11-03 $ 148.65 (0.95%)
7:26am
10:34pm
2020-11-02 $ 147.25 (2.19%)
5:35pm
2020-10-30 $ 144.1 (-1.05%)
7:43am
2020-10-26 $ 148.93 (-0.89%)
11:31am
2020-10-20 $ 148.42 (0.47%)
9:56am
2020-10-18
6:36am
2020-10-16 $ 149.97 (-0.3%)
4:38pm
2020-10-14 $ 152.2 (0.07%)
4:09am
2020-10-09 $ 155.41 (0.38%)
11:42am
8:48am
2020-10-07 $ 143.32 (1.8%)
7:21am
2020-10-06 $ 140.79 (-2.57%)
11:57am
7:15pm
2020-10-05 $ 144.5 (0.7%)
10:40am
2020-10-04
8:23am
2020-09-23 $ 138.07 (-0.82%)
6:10am
2020-09-17 $ 140.15 (-2.76%)
10:40am
2020-09-04 $ 131.7 (-1.98%)
11:47am
8:15am
2020-09-03 $ 134.36 (-1.31%)
10:31am
2020-09-01 $ 135.45 (0.79%)
11:20am
10:40am
2020-08-05 $ 122.24 (10.64%)
11:10am
6:38am
2020-08-04 $ 110.48 (-1.3%)
5:45pm
2020-07-28 $ 113.95 (0.35%)
11:33am
2020-07-22 $ 110.26 (4.49%)
1:49pm
2020-07-09 $ 105.46 (-1.93%)
1:02pm
2020-07-06 $ 111.2 (1.32%)
1:49pm
2020-06-23 $ 114.05 (1.08%)
7:06am
2020-06-16 $ 111.58 (0.98%)
9:15am
7:33am
2020-06-04 $ 121.88 (2.64%)
10:31am
2020-06-01 $ 119.37 (0.04%)
12:56pm
2020-05-21 $ 110.85 (-3.12%)
3:21pm
2020-05-09
8:10am
2020-05-06 $ 113.3 (2.62%)
10:39am
10:38am
7:00am
10:29pm
2020-05-05 $ 110.41 (1.55%)
5:45pm
2020-05-04 $ 108.73 (-0.78%)
9:57am
2020-05-03
7:36am
2020-04-28 $ 112.38 (2.07%)
11:33am
11:10am
10:48am
2020-03-26 $ 100.74 (5.33%)
10:30am
8:59am
2020-03-25 $ 95.64 (0.02%)
7:21am
2019-12-04 $ 148.16 (1.17%)
5:15pm
2019-11-15 $ 138.64 (3.6%)
8:38am
2019-10-09 $ 118.91 (0.28%)
4:38pm
2019-05-07 $ 128.65 (-3.13%)
11:07am
2018-11-29 $ 147.52 (0.74%)
11:00am
2018-07-12 $ 179.46 (-0.23%)
10:43am
2018-04-24 $ 154.51 (-0.73%)
11:25am
2017-01-11 $ 115.7 (-0.36%)
2:21pm
2016-11-29 $ 105.84 (-2.04%)
9:58am
Total 112
  • 1
  • 2